Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Devic's optic neuromyelitis. 4 cases].

D Leys1, H Petit, A M Block

  • 1Service de Neurologie, CHU de Lille.

Revue Neurologique
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute stroke care in France: Survey in the 138 stroke units.

Revue neurologique·2022
Same author

Spinal infarcts.

Revue neurologique·2021
Same author

The first case of traumatic internal carotid arterial dissection? Verneuil's case report from 1872.

Revue neurologique·2020
Same author

EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke.

European journal of neurology·2020
Same author

How can neurology be affected by the '100 Radical Innovation Breakthroughs for the Future' report of the European Commission?

European journal of neurology·2020
Same author

Cerebral ischaemia with unknown onset: Outcome after recanalization procedure.

Revue neurologique·2019
Same journal

Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study.

Revue neurologique·2026
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
See all related articles

Neuromyelitis optica (Devic's disease) presents with optic neuritis and myelitis. While spinal cord recovery is good, visual prognosis is poor, and cases suggest differentiation from multiple sclerosis.

Area of Science:

  • Neuroimmunology
  • Neurology

Background:

  • Neuromyelitis optica (NMO), or Devic's disease, is a rare autoimmune disorder affecting the central nervous system.
  • Characterized by simultaneous or sequential attacks of optic neuritis and myelitis, NMO requires accurate diagnosis and differentiation from other demyelinating diseases.

Observation:

  • This study reports on 4 cases of NMO with 3-7 year follow-up for 3 patients.
  • Observed features included subacute onset, optic neuritis and myelitis association, and effectiveness of corticosteroids on spinal cord lesions.
  • Rare presentations noted were unilateral visual disturbance, complete visual recovery in one case, childhood onset, onset post-meningitis, and corticosteroid dependency.

Findings:

  • NMO cases exhibited typical features like absence of relapse and poor visual prognosis, contrasting with good paraplegia prognosis.

Related Experiment Videos

  • Magnetic Resonance Imaging (MRI) revealed disseminated demyelinated areas, indicating lesions potentially larger than clinically apparent.
  • Patients showed no significant immunological disturbances, and cerebrospinal fluid (CSF) analysis indicated high cell and protein levels.

    • Implications:

    • The distinct clinical and imaging findings, particularly poor visual prognosis and inflammatory markers, support differentiating NMO from multiple sclerosis (MS).
    • These observations highlight the importance of early diagnosis and tailored treatment strategies for NMO patients.
    • Further research into the specific immunopathogenesis of NMO is warranted to improve therapeutic outcomes and patient management.